FI974441A0 - Vedettömän 7-(/1alfa,5alfa,6alfa/-6-amino-3-atsabisyklo(3.1.0)heks-3-yyli)-6-fluori-1-(2,4-difluorifenyyli)-1,4-dihydro-4-okso,1,8-naftyridiini-3-karboksyylihapon metaanisulfonihapposuolan uusi kidemuoto - Google Patents

Vedettömän 7-(/1alfa,5alfa,6alfa/-6-amino-3-atsabisyklo(3.1.0)heks-3-yyli)-6-fluori-1-(2,4-difluorifenyyli)-1,4-dihydro-4-okso,1,8-naftyridiini-3-karboksyylihapon metaanisulfonihapposuolan uusi kidemuoto

Info

Publication number
FI974441A0
FI974441A0 FI974441A FI974441A FI974441A0 FI 974441 A0 FI974441 A0 FI 974441A0 FI 974441 A FI974441 A FI 974441A FI 974441 A FI974441 A FI 974441A FI 974441 A0 FI974441 A0 FI 974441A0
Authority
FI
Finland
Prior art keywords
6alpha
5alpha
1alpha
naphthyridine
azabicyclo
Prior art date
Application number
FI974441A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974441L (fi
FI974441A7 (fi
Inventor
Lynne A Handanyan
Robert L Hendrickson
Phillip J Johnson
Thomas A Morris
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974441L publication Critical patent/FI974441L/fi
Publication of FI974441A7 publication Critical patent/FI974441A7/fi
Publication of FI974441A0 publication Critical patent/FI974441A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI974441A 1995-06-06 1995-06-06 Vedettömän 7-(/1alfa,5alfa,6alfa/-6-amino-3-atsabisyklo(3.1.0)heks-3-yyli)-6-fluori-1-(2,4-difluorifenyyli)-1,4-dihydro-4-okso,1,8-naftyridiini-3-karboksyylihapon metaanisulfonihapposuolan uusi kidemuoto FI974441A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (3)

Publication Number Publication Date
FI974441L FI974441L (fi) 1997-12-05
FI974441A7 FI974441A7 (fi) 1997-12-05
FI974441A0 true FI974441A0 (fi) 1997-12-05

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974441A FI974441A0 (fi) 1995-06-06 1995-06-06 Vedettömän 7-(/1alfa,5alfa,6alfa/-6-amino-3-atsabisyklo(3.1.0)heks-3-yyli)-6-fluori-1-(2,4-difluorifenyyli)-1,4-dihydro-4-okso,1,8-naftyridiini-3-karboksyylihapon metaanisulfonihapposuolan uusi kidemuoto

Country Status (38)

Country Link
US (1) US5763454A (cs)
EP (1) EP0789697B1 (cs)
JP (1) JP3145715B2 (cs)
KR (1) KR100191989B1 (cs)
CN (1) CN1055474C (cs)
AR (1) AR002753A1 (cs)
AU (1) AU703634B2 (cs)
BG (1) BG62443B1 (cs)
BR (1) BR9602630A (cs)
CA (1) CA2223404C (cs)
CZ (1) CZ285878B6 (cs)
DE (1) DE69503066T2 (cs)
DK (1) DK0789697T3 (cs)
DZ (1) DZ2046A1 (cs)
ES (1) ES2117426T3 (cs)
FI (1) FI974441A0 (cs)
HR (1) HRP960267B1 (cs)
HU (1) HUP9601540A3 (cs)
IL (1) IL118488A (cs)
IS (1) IS4351A (cs)
LV (1) LV11619B (cs)
MA (1) MA23892A1 (cs)
NO (1) NO305599B1 (cs)
NZ (1) NZ286735A (cs)
OA (1) OA10293A (cs)
PE (1) PE38097A1 (cs)
PL (1) PL314604A1 (cs)
RU (1) RU2125571C1 (cs)
SG (1) SG54339A1 (cs)
SI (1) SI9600185A (cs)
SK (1) SK280535B6 (cs)
TN (1) TNSN96084A1 (cs)
TW (2) TW403751B (cs)
UA (1) UA44718C2 (cs)
UY (1) UY25459A1 (cs)
WO (1) WO1996039406A1 (cs)
YU (1) YU34596A (cs)
ZA (1) ZA964647B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) * 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) * 2013-01-11 2017-12-21 參天製藥股份有限公司 內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
BR9408490A (pt) * 1994-01-18 1997-08-26 Pfizer Processo e intermediários para a preparação de sais do ácido nafftiridonocarboxílico
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
CA2223404C (en) 2001-01-16
CZ285878B6 (cs) 1999-11-17
DZ2046A1 (fr) 2002-10-22
YU34596A (sh) 1999-03-04
FI974441L (fi) 1997-12-05
MA23892A1 (fr) 1996-12-31
NO305599B1 (no) 1999-06-28
PE38097A1 (es) 1997-10-10
DE69503066T2 (de) 1998-10-15
MX9709873A (es) 1998-03-31
AU5474996A (en) 1996-12-19
NO962321D0 (no) 1996-06-05
EP0789697A1 (en) 1997-08-20
UY25459A1 (es) 1999-11-17
US5763454A (en) 1998-06-09
DE69503066D1 (de) 1998-07-23
PL314604A1 (en) 1996-12-09
BG100639A (bg) 1997-02-28
ZA964647B (en) 1997-10-22
SK71996A3 (en) 1997-03-05
JPH10506650A (ja) 1998-06-30
JP3145715B2 (ja) 2001-03-12
ES2117426T3 (es) 1998-08-01
HUP9601540A3 (en) 1997-05-28
IL118488A (en) 1999-01-26
HRP960267B1 (en) 2000-06-30
AR002753A1 (es) 1998-04-29
SK280535B6 (sk) 2000-03-13
TNSN96084A1 (fr) 2005-03-15
LV11619B (en) 1997-04-20
NO962321L (no) 1996-12-09
CA2223404A1 (en) 1996-12-12
OA10293A (en) 1997-09-19
KR100191989B1 (ko) 1999-06-15
FI974441A7 (fi) 1997-12-05
TW580389B (en) 2004-03-21
IS4351A (is) 1996-12-07
DK0789697T3 (da) 1998-10-19
RU2125571C1 (ru) 1999-01-27
KR970001352A (ko) 1997-01-24
TW403751B (en) 2000-09-01
HU9601540D0 (en) 1996-07-29
IL118488A0 (en) 1996-09-12
LV11619A (lv) 1996-12-20
EP0789697B1 (en) 1998-06-17
BG62443B1 (bg) 1999-11-30
CZ162596A3 (cs) 1998-09-16
WO1996039406A1 (en) 1996-12-12
HRP960267A2 (en) 1997-08-31
NZ286735A (en) 1998-01-26
UA44718C2 (uk) 2002-03-15
SI9600185A (en) 1997-04-30
CN1055474C (zh) 2000-08-16
HUP9601540A2 (en) 1997-02-28
CN1148596A (zh) 1997-04-30
AU703634B2 (en) 1999-03-25
SG54339A1 (en) 1998-11-16
BR9602630A (pt) 1998-09-08

Similar Documents

Publication Publication Date Title
FI974441A0 (fi) Vedettömän 7-(/1alfa,5alfa,6alfa/-6-amino-3-atsabisyklo(3.1.0)heks-3-yyli)-6-fluori-1-(2,4-difluorifenyyli)-1,4-dihydro-4-okso,1,8-naftyridiini-3-karboksyylihapon metaanisulfonihapposuolan uusi kidemuoto
IT8722220A0 (it) Metodo per la preparazione di titanio silicaliti.
PT1191025E (pt) Cristais de lansoprazol
FI882890L (fi) Faktor viii:c-lik molekyl med koagulationsaktivitet.
NO905255D0 (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
MX11117A (es) Procedimiento para la preparacion de nuevos antagonistas opioides de la piperidina.
NO905008L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO881537L (no) Fremgangsmaate for fremstilling av 6-substituert-2',3'-dideoksynukleosider.
IT1283232B1 (it) Procedimento per la sintesi di 2-buten-1, 4-diesteri
NO166283C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater.
FI921641A7 (fi) Menetelmä lääkeaineina käyttökelpoisten 1-(pyrido/3,4-b/-1,4-oksatsin-4-yyli)-1H-indolien valmistamiseksi
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
ITMI910353A0 (it) Procedimento per la cristallizzazioe di triptofano otticamente attivo
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
FI881075A7 (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
PT1133496E (pt) Modificacao cristalina a de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|nonan-8-il)-6-fluoro-1,4-di-hidro-4-oxo-3-quinolinocarboxilico
AP9600851A0 (en) Novel crystal form of anhydrous 7-(1A,5A,6A) -6- amino-3- azabicyclo(3.1.0)hex-3-YL) -6- fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo1,8-naphthyridine S-3-carboxylic acid methanesulfonic acid salt
ES2023410B3 (es) Acidos 1,3,4,9-tetrahidropiran 3,4-b]indol -1 aceticos sustituidos.
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
NO872358D0 (no) Fremgangsmaate for 2,3-dihydro-1-(8-methyl-1,2,4-triazolo-(4,3-b)pyridazin-6-yl)-4(1h)-pyridinoner.
NO891564D0 (no) Fremgangsmaate for undervanns-peling av lange vertikale hulpeler.
ATE167478T1 (de) Kristallform von wasserfreien 7-((1a,5a,6a)-6- amino-3-azabicyclo (3.1.0.) hex-3-yl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8- naphthyridin-carbonsäure methanesulfonsäure salz
FI943730A0 (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi
IT8719073A0 (it) Procedimento per la preparazione di omega-isopropossifenolo.
FI864493A0 (fi) Anordning foer sterilisering av vaetska med uv-ljus.